サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1571885

カンナビジオールの世界市場

Cannabidiol

出版日
ページ情報
英文 96 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
カンナビジオールの世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 96 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

カンナビジオールの世界市場は2030年までに212億米ドルに達する見込み

2023年に81億米ドルと推定されるカンナビジオールの世界市場は、分析期間2023-2030年にCAGR 14.6%で成長し、2030年には212億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるヘンプは、CAGR15.9％を記録し、分析期間終了時には143億米ドルに達すると予想されます。マリファナ分野の成長率は、分析期間中CAGR 12.4％と推定されます。

米国市場は21億米ドルと推定、中国はCAGR19.5％で成長予測

米国のカンナビジオール市場は2023年に21億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに54億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは19.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.4%と12.8%と予測されています。欧州では、ドイツがCAGR 11.9%で成長すると予測されています。

世界のカンナビジオール（CBD）市場- 主要動向と促進要因まとめ

カンナビジオール（CBD）が世界的に人気を集めている理由とは？

カンナビジオール（CBD）は、特に慢性疼痛、不安、てんかん、その他の病状の管理など、その幅広い健康上の利点と治療用途により、世界中で急速に人気を集めています。大麻の精神活性成分であるテトラヒドロカンナビノール（THC）とは異なり、CBDは「ハイ」を引き起こさないため、大麻のような精神に作用することなく様々な病気の緩和を求める人々にとって、より魅力的な選択肢となっています。大麻植物に由来するCBDは、オイル、カプセル、食用、クリーム、チンキ剤など様々な形態で販売されており、多様な消費者層に利用しやすくなっています。CBDの台頭は、自然療法や代替療法に対する消費者の関心の高まりと、カンナビノイドの潜在的な健康効果に対する意識の高まりによるところが大きいです。

いくつかの国で医療用や娯楽用の大麻が広く合法化されたことで、CBD製品の需要はさらに加速しています。消費者が植物由来のホリスティックな治療法にますます目を向けるようになる中、CBDはストレス、炎症、睡眠障害、その他の健康上の懸念の緩和を求める人々にとって好ましい選択肢となっています。FDAがエピディオレックス（てんかん治療用のCBDベースの医薬品）を承認したことで証明されるように、てんかんのような神経疾患を管理するためのCBDの可能性に関する調査は、その治療の可能性に信頼性を加え、世界市場の成長に拍車をかけています。

技術の進歩はCBD産業をどのように形成していますか？

CBDの抽出、製剤化、生産における技術の進歩が市場を大きく変えています。CO2抽出のような、より効率的な抽出方法の開発により、製造業者は不要な物質を除去しながら大麻植物の有益な化合物を保持する、より純度の高いCBD製品を製造できるようになりました。この抽出技術の向上により、消費者はより安全で、より安定した、より強力なCBD製品を入手できるようになりました。さらに、ナノエマルジョン技術の革新により、水溶性CBDの生産が可能になり、生物学的利用能と吸収が向上し、CBD製品が低用量でより効果的になります。

もう一つの注目すべき進歩は、製品開発とカスタマイズの分野です。CBDに対する消費者の需要が伸び続ける中、製造業者は特定の消費者のニーズをターゲットに、飲料からスキンケアラインまで、多様なCBD入り製品を生み出しています。CBDの嗜好品、飲料、パーソナルケア製品の台頭は、メーカーが異なる市場に対応するためにどのように革新しているかを浮き彫りにしています。さらに、検査と分析ツールの進歩はCBD製品の安全性と規制を改善し、必要な品質基準を満たしていることを保証しています。技術が進化し続けるにつれて、製品の処方や送達方法における更なる革新につながり、健康とウェルネスにおけるCBDの応用範囲を広げることになるでしょう。

消費者の嗜好の変化はCBD市場にどのような影響を与えていますか？

消費者の嗜好の変化、特に自然で健康志向の製品へのシフトはCBD市場の形成に極めて重要な役割を果たしています。今日の消費者は健康志向が強く、従来の医薬品に代わる自然なものを積極的に求めています。CBDは植物由来であり、様々な健康問題に対する自然療法として販売されることが多いため、このプロファイルに完璧に当てはまります。セルフケアと健康志向の動向の高まりにより、CBD製品は、リラクゼーション、疼痛管理、スキンケアにCBDオイルやクリームを使用するなど、ますます日常生活に取り入れられています。また、消費者が持続可能性と健康という価値観に沿った製品を求めているため、クリーンラベル、オーガニック、非遺伝子組み換えのCBD製品に対する需要も増加しています。

さらに、ヘルスケアとウェルネスにおけるパーソナライゼーションの動向は、カスタマイズされたCBDソリューションの需要を促進しています。消費者は、特定の健康状態やライフスタイル、あるいは嗜好に合わせたCBD製品を求めています。例えば、ストレス緩和や運動能力の回復、あるいは睡眠強化のためのCBD入り製品などです。個別化されたウェルネス・ソリューションへの関心の高まりにより、企業は製品ラインを拡大し、こうした需要に応えるために的を絞ったマーケティング戦略を立てるようになりました。さらに、より多くの消費者がCBDの潜在的な利点について知識を深めるにつれて、主流サプリメントとしてのCBDの受容性が高まり、市場の成長をさらに促進しています。

カンナビジオール（CBD）市場の成長はいくつかの要因別牽引される

カンナビジオール（CBD）市場の成長は、その健康上の利点に対する消費者の意識の高まり、様々な地域における大麻の合法化、製品提供の拡大など、いくつかの要因によって牽引されています。より多くの消費者が疼痛緩和、不安管理、その他の健康状態のためにCBDに目を向けているため、伝統的な薬に代わる自然なものへの需要の高まりが重要な推進力となっています。特にてんかん、慢性疼痛、炎症などの症状に対するCBDの治療的可能性を支持する科学的研究の高まりも、CBD製品の幅広い採用を後押ししています。

合法化と規制の変更も市場成長を後押しする大きな要因です。北米、欧州、アジアの一部でCBDの使用を規制する法律が緩和されたことで、市場拡大の新たな機会が生まれました。大麻とCBDが合法的に入手できる国では、消費者が栄養補助食品からペット用品までCBDの潜在的な用途をますます探求しており、市場は急成長を遂げています。さらに、大手小売チェーンがCBD市場に参入し、オンライン流通チャンネルもできたことで、CBD製品は世界中の消費者にとってより身近なものになりました。さらに、ウェルネスとホリスティックヘルスへの関心の高まりが、美容やパーソナルケア業界におけるCBDの使用の増加とともに、この分野の成長に寄与しています。大麻に対するスティグマが薄れ続け、より多くの消費者がウェルネスと代替治療を優先するようになるにつれ、CBD市場は持続的な成長が見込まれ、新製品のイノベーションと用途の拡大が様々な産業における需要を牽引しています。

調査対象企業の例（全47件）

  • ABcann Medicinals, Inc.
  • Aphria, Inc
  • Aurora Cannabis
  • Canopy Growth Corporation
  • CBD LION
  • CBDfxBota
  • CBDistillery
  • cbdMD
  • GW Pharmaceuticals, plc
  • Kazmira
  • Maricann, Inc.（Wayland Group Corporation）
  • Medixcbd
  • Medterra
  • NuLeaf Naturals
  • Organigram Holding, Inc.
  • The CBD Company
  • The Cronos Group
  • Tikun Olam
  • Tilray

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21415

Global Cannabidiol Market to Reach US$21.2 Billion by 2030

The global market for Cannabidiol estimated at US$8.1 Billion in the year 2023, is expected to reach US$21.2 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Hemp, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$14.3 Billion by the end of the analysis period. Growth in the Marijuana segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 19.5% CAGR

The Cannabidiol market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 19.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.4% and 12.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.

Global Cannabidiol (CBD) Market – Key Trends & Drivers Summarized

Why Is Cannabidiol (CBD) Gaining Global Popularity?

Cannabidiol (CBD) has rapidly gained popularity across the globe due to its wide range of health benefits and therapeutic applications, particularly in managing chronic pain, anxiety, epilepsy, and other medical conditions. Unlike tetrahydrocannabinol (THC), the psychoactive component of cannabis, CBD does not produce a "high," making it a more appealing option for those seeking relief from various ailments without the mind-altering effects of marijuana. Derived from the cannabis plant, CBD is available in various forms, including oils, capsules, edibles, creams, and tinctures, making it accessible to a diverse consumer base. Its rise is largely driven by increasing consumer interest in natural and alternative treatments, as well as growing awareness about the potential health benefits of cannabinoids.

The widespread legalization of cannabis for medical and recreational use in several countries has further accelerated the demand for CBD products. With consumers increasingly turning to plant-based and holistic remedies, CBD has become a preferred option for those seeking relief from stress, inflammation, sleep disorders, and other health concerns. Research into CBD's potential to manage neurological conditions, such as epilepsy, as evidenced by the FDA's approval of Epidiolex (a CBD-based drug for epilepsy treatment), has added credibility to its therapeutic potential, fueling growth in the global market.

How Are Technological Advancements Shaping the CBD Industry?

Technological advancements in the extraction, formulation, and production of CBD are significantly transforming the market. The development of more efficient extraction methods, such as CO2 extraction, has allowed manufacturers to produce higher-purity CBD products that retain the beneficial compounds of the cannabis plant while eliminating unwanted substances. This improvement in extraction technology ensures that consumers have access to safer, more consistent, and more potent CBD products. Moreover, innovations in nanoemulsion technology are enabling the production of water-soluble CBD, which enhances bioavailability and absorption, making CBD products more effective at lower doses.

Another notable advancement is in the area of product development and customization. As consumer demand for CBD continues to grow, manufacturers are creating a diverse range of CBD-infused products, from beverages to skincare lines, targeting specific consumer needs. The rise of CBD edibles, beverages, and personal care products highlights how manufacturers are innovating to cater to different markets. Additionally, advancements in testing and analytics tools have improved the safety and regulation of CBD products, ensuring that they meet the necessary quality standards. As technology continues to evolve, it will likely lead to further innovations in product formulation and delivery methods, broadening the scope of CBD's application in health and wellness.

How Are Changing Consumer Preferences Influencing the CBD Market?

Changing consumer preferences, particularly the shift toward natural and wellness-oriented products, are playing a pivotal role in shaping the CBD market. Today’s consumers are more health-conscious and are actively seeking out natural alternatives to conventional pharmaceuticals. CBD fits this profile perfectly, as it is derived from plants and is often marketed as a natural remedy for various health issues. The growing trend toward self-care and wellness has seen CBD products increasingly integrated into daily routines, such as using CBD oils or creams for relaxation, pain management, or skin care. The demand for clean-label, organic, and non-GMO CBD products is also on the rise, as consumers seek out products that align with their values of sustainability and health.

Additionally, the trend of personalization in healthcare and wellness is driving the demand for customized CBD solutions. Consumers are looking for CBD products tailored to specific health conditions, lifestyles, or preferences, such as CBD-infused products for stress relief, athletic recovery, or enhanced sleep. This growing interest in personalized wellness solutions has prompted companies to expand their product lines and create targeted marketing strategies to meet these demands. Moreover, as more consumers become educated about the potential benefits of CBD, its acceptance as a mainstream supplement is increasing, further driving market growth.

Growth in the Cannabidiol (CBD) Market Is Driven by Several Factors

The growth in the cannabidiol (CBD) market is driven by several factors, including increasing consumer awareness of its health benefits, the legalization of cannabis in various regions, and the expansion of product offerings. The rising demand for natural alternatives to traditional medications is a significant driver, as more consumers are turning to CBD for pain relief, anxiety management, and other health conditions. The growing body of scientific research supporting the therapeutic potential of CBD, particularly for conditions like epilepsy, chronic pain, and inflammation, is also encouraging wider adoption of CBD products.

Legalization and regulatory changes are another major factor fueling market growth. The relaxation of laws governing the use of CBD in North America, Europe, and parts of Asia has created new opportunities for market expansion. In countries where cannabis and CBD are legally accessible, the market is experiencing rapid growth, with consumers increasingly exploring the potential uses of CBD in everything from dietary supplements to pet products. Additionally, the entry of major retail chains into the CBD market, along with online distribution channels, has made CBD products more accessible to consumers globally. Furthermore, the rising interest in wellness and holistic health, along with the increasing use of CBD in the beauty and personal care industry, is contributing to the sector's growth. As the stigma around cannabis continues to fade and more consumers prioritize wellness and alternative treatments, the CBD market is expected to see sustained growth, with new product innovations and expanded applications driving demand across a variety of industries.

Select Competitors (Total 47 Featured) -

  • ABcann Medicinals, Inc.
  • Aphria, Inc
  • Aurora Cannabis
  • Canopy Growth Corporation
  • CBD LION
  • CBDfxBota
  • CBDistillery
  • cbdMD
  • GW Pharmaceuticals, plc
  • Kazmira
  • Maricann, Inc. (Wayland Group Corporation)
  • Medixcbd
  • Medterra
  • NuLeaf Naturals
  • Organigram Holding, Inc.
  • The CBD Company
  • The Cronos Group
  • Tikun Olam
  • Tilray

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cannabidiol - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Evolution of Global Legalization and Regulatory Frameworks Dramatically Expands Market Opportunities for Cannabidiol (CBD) Products
    • Surging Consumer Interest and Increased Public Awareness Propel the Demand for CBD in Health and Wellness Applications
    • Significant Advancements in Clinical Research Highlight the Therapeutic Potential of CBD, Broadening its Use in Medical Treatments
    • Expansion of Retail Distribution Channels Enhances Consumer Accessibility and Spurs Growth in the CBD Market
    • Technological Innovations in CBD Extraction and Purification Processes Enhance Product Quality and Consumer Trust
    • Increasing Adoption of CBD-Based Products Among the Elderly Population Strengthens Market Penetration and Reach
    • Integration of CBD into Cosmetics and Personal Care Lines Opens New Avenues in the Fast-Growing Beauty Industry
    • Rising Global Pet Ownership and the Growing Acceptance of CBD for Pet Health and Wellness Drive Product Line Diversification
    • Growing Endorsements from Athletes and Integration of CBD in Sports Recovery Products Propel Market Visibility and Acceptance
    • Enhanced Consumer Focus on Natural and Organic Ingredients Amplifies the Business Case for CBD in the Nutraceutical Sector
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Personal Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Personal Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Personal Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Cannabidiol Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cannabidiol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hemp by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hemp by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hemp by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • JAPAN
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • CHINA
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • EUROPE
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cannabidiol by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • FRANCE
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • GERMANY
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Cannabidiol by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • INDIA
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Cannabidiol by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Cannabidiol by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
  • AFRICA
    • Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030

IV. COMPETITION